{"id":"observation-arm","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL3896316","moleculeType":"Small molecule","molecularWeight":"654.59"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"An observation arm serves as a control or comparator group in clinical trials where patients are followed prospectively to document disease course, standard care patterns, and outcomes without receiving the investigational drug. This allows researchers to establish baseline natural history and compare it against treated populations.","oneSentence":"An observation arm is a non-interventional study group used to monitor natural disease progression or outcomes without active drug treatment.","_ai_confidence":"low"},"_scrapedAt":"2026-03-27T23:57:57.707Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT03055013","phase":"PHASE3","title":"Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2017-04-28","conditions":"Metastatic Renal Cell Carcinoma, Sarcomatoid Renal Cell Carcinoma, Stage II Renal Cell Cancer AJCC v7","enrollment":819},{"nctId":"NCT06498635","phase":"PHASE3","title":"Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2025-04-01","conditions":"Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8","enrollment":306},{"nctId":"NCT05064293","phase":"NA","title":"Assisted Identification and Navigation of Early Mental Health Symptoms in Children","status":"COMPLETED","sponsor":"Kaiser Permanente","startDate":"2021-09-07","conditions":"Adolescent Behavior, Mental Health Issue","enrollment":358},{"nctId":"NCT06099015","phase":"","title":"Cera™ Vascular Plug System Post-Market Clinical Follow-Up","status":"RECRUITING","sponsor":"Lifetech Scientific (Shenzhen) Co., Ltd.","startDate":"2024-06-21","conditions":"Aneurysm, Endoleak, Pulmonary Arteriovenous Malformation","enrollment":132},{"nctId":"NCT03811015","phase":"PHASE3","title":"Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2019-08-16","conditions":"Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8","enrollment":636},{"nctId":"NCT03574909","phase":"PHASE3","title":"IRELAnD: Investigating the Role of Early Low-dose Aspirin in Diabetes","status":"COMPLETED","sponsor":"Royal College of Surgeons, Ireland","startDate":"2018-09-01","conditions":"Pre-Gestational Diabetes","enrollment":137},{"nctId":"NCT07422766","phase":"","title":"Comparison of Non-Invasive Mean Arterial Blood Pressure Measurements at the Arm and Ankle During Elective Cesarean Delivery.","status":"RECRUITING","sponsor":"St. Justine's Hospital","startDate":"2026-02-26","conditions":"Pregnancy, Cesarean Delivery, Blood Pressure Measurement in Pregnancy","enrollment":110},{"nctId":"NCT05058651","phase":"PHASE2, PHASE3","title":"Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2022-06-28","conditions":"Advanced Extrapulmonary Neuroendocrine Carcinoma, Metastatic Extrapulmonary Neuroendocrine Carcinoma, Recurrent Extrapulmonary Neuroendocrine Carcinoma","enrollment":189},{"nctId":"NCT03233711","phase":"PHASE3","title":"Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2018-07-05","conditions":"Anal Basaloid Carcinoma, Anal Canal Cloacogenic Carcinoma, Anal Margin Squamous Cell Carcinoma","enrollment":344},{"nctId":"NCT07495787","phase":"NA","title":"Magnetic Compression Anastomosis Procedure for Partial Jejunoileal Anastomosis: Assessing the Viability of an Innovative Metabolic Approach","status":"RECRUITING","sponsor":"iIDEAS Group Holdings Limited","startDate":"2025-04-22","conditions":"Diabete Type 2","enrollment":5},{"nctId":"NCT05324683","phase":"","title":"ILUMIEN-V - AERO: All-comEr Registry of OCT (AERO)","status":"ACTIVE_NOT_RECRUITING","sponsor":"IHF GmbH - Institut für Herzinfarktforschung","startDate":"2023-05-04","conditions":"Myocardial Ischemia","enrollment":2000},{"nctId":"NCT07494630","phase":"NA","title":"Joint Endoprostheses Can Succesfully Treat Disabling Osteoarthritis. However, Infection is an Important Cause of Failure. Adequate Diagnostics Remains Challenging. Combining Advanced Imaging With Next-generation Sequencing of Samples Obtained Endoscopically Should Aid in Mapping and Characterizing.","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Hospital, Ghent","startDate":"2018-09-18","conditions":"Chronic Periprosthetic Joint Infection, Suspected Periprosthetic Joint Infection, Prosthetic Joint Failure of Unclear Etiology","enrollment":174},{"nctId":"NCT02595944","phase":"PHASE3","title":"Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2016-07-22","conditions":"Stage IB Lung Non-Small Cell Carcinoma AJCC v7, Stage II Lung Non-Small Cell Cancer AJCC v7, Stage IIIA Lung Non-Small Cell Cancer AJCC v7","enrollment":903},{"nctId":"NCT03712605","phase":"PHASE3","title":"Testing Pembrolizumab Versus Observation in Patients With Merkel Cell Carcinoma After Surgery, STAMP Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2018-11-15","conditions":"Pathologic Stage I Cutaneous Merkel Cell Carcinoma AJCC v8, Pathologic Stage II Cutaneous Merkel Cell Carcinoma AJCC v8, Pathologic Stage III Cutaneous Merkel Cell Carcinoma AJCC v8","enrollment":280},{"nctId":"NCT02954874","phase":"PHASE3","title":"Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2017-01-18","conditions":"Invasive Breast Carcinoma, Stage 0 Breast Cancer AJCC v6 and v7, Stage I Breast Cancer AJCC v7","enrollment":1155},{"nctId":"NCT03737981","phase":"PHASE3","title":"Testing the Addition of a New Anti-cancer Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Obinutuzumab) in Untreated, Older Patients With Chronic Lymphocytic Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2019-01-31","conditions":"Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma","enrollment":465},{"nctId":"NCT02275533","phase":"PHASE2","title":"Testing Nivolumab to Prevent Disease From Coming Back After Treatment in Patients With Acute Myeloid Leukemia, REMAIN Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2015-07-02","conditions":"Acute Myeloid Leukemia","enrollment":82},{"nctId":"NCT07498738","phase":"NA","title":"Making Diabetes Care Fit for Young Adults Living With Type 1 Diabetes: Observations, Reflections and Expert Opinions","status":"NOT_YET_RECRUITING","sponsor":"Leiden University Medical Center","startDate":"2026-03-13","conditions":"Type 1 Diabetes","enrollment":60},{"nctId":"NCT05235126","phase":"NA","title":"A Clinical Investigation of the Decoria® Aesthetic Group (DAG) for Correction of Nasolabial Folds (NLF)","status":"COMPLETED","sponsor":"Bohus Biotech AB","startDate":"2022-02-17","conditions":"Correction of Nasolabial Folds","enrollment":94},{"nctId":"NCT07388524","phase":"PHASE3","title":"Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2026-04-09","conditions":"Lung Non-Small Cell Carcinoma","enrollment":336},{"nctId":"NCT00217737","phase":"PHASE3","title":"Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2005-09-06","conditions":"Colon Adenocarcinoma, Stage IIA Colon Cancer AJCC v7, Stage IIB Colon Cancer AJCC v7","enrollment":2431},{"nctId":"NCT05601440","phase":"PHASE2","title":"Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer","status":"RECRUITING","sponsor":"Canadian Cancer Trials Group","startDate":"2023-06-13","conditions":"Breast Cancer","enrollment":484},{"nctId":"NCT03244384","phase":"PHASE3","title":"Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2017-11-03","conditions":"Localized Renal Pelvis and Ureter Urothelial Carcinoma, Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis and Ureter Urothelial Carcinoma","enrollment":739},{"nctId":"NCT07497815","phase":"","title":"Artificial Intelligence-assisted Diagnosis in Ophthalmology","status":"NOT_YET_RECRUITING","sponsor":"Marisse Masis-Solano","startDate":"2026-05-01","conditions":"Macular Degeneration, Diabetic Retinopathy (DR), Glaucoma","enrollment":15000},{"nctId":"NCT02193282","phase":"PHASE3","title":"Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2015-02-11","conditions":"Lung Non-Squamous Non-Small Cell Carcinoma, Stage IB Lung Non-Small Cell Carcinoma AJCC v7, Stage II Lung Non-Small Cell Cancer AJCC v7","enrollment":390},{"nctId":"NCT04267848","phase":"PHASE3","title":"Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2020-06-16","conditions":"Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma, Lung Non-Squamous Non-Small Cell Carcinoma","enrollment":1210},{"nctId":"NCT02194738","phase":"NA","title":"Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2014-09-26","conditions":"Stage IB Lung Non-Small Cell Carcinoma AJCC v7, Stage II Lung Non-Small Cell Cancer AJCC v7, Stage IIA Lung Cancer AJCC v8","enrollment":8300},{"nctId":"NCT01251861","phase":"PHASE2","title":"Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2010-12-23","conditions":"Recurrent Prostate Carcinoma, Stage I Prostate Cancer AJCC v7, Stage IIA Prostate Cancer AJCC v7","enrollment":108},{"nctId":"NCT07096388","phase":"","title":"Evaluation Of Cost-Effectiveness Of Iliac Branch Endoprostheses","status":"NOT_YET_RECRUITING","sponsor":"Prof. Andrea Kahlberg","startDate":"2026-05-01","conditions":"Aorto-iliac Aneurysm","enrollment":300},{"nctId":"NCT05755412","phase":"","title":"Shockwave ®S4 Catheter IVL to Treat Infrapopliteal Calcified Stenoses and/or Occlusions in CLTI Patients (LEGACY)","status":"TERMINATED","sponsor":"EndoCore Lab s.r.l.","startDate":"2023-03-14","conditions":"Peripheral Arterial Disease, Critical Limb-Threatening Ischaemia","enrollment":9},{"nctId":"NCT07384364","phase":"","title":"Observational Study Evaluating Robotic Spinal Mobilization in 16 Parkinson's Disease Participants. The Study Recorded Changes in Mobility, Sit-to-stand Performance, and Pain Scores After a 2-week Intervention With the BackHug Device.","status":"COMPLETED","sponsor":"Pacla Medical Limited","startDate":"2025-09-24","conditions":"Parkinson's Disease (PD)","enrollment":19},{"nctId":"NCT06834035","phase":"PHASE1, PHASE2","title":"Targeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis Bullosa","status":"RECRUITING","sponsor":"M. Peter Marinkovich","startDate":"2025-08-04","conditions":"Epidermolysis Bullosa, Epidermolysis Bullosa Acquisita, Dystrophic Epidermolysis Bullosa","enrollment":8},{"nctId":"NCT04383119","phase":"PHASE2","title":"Trial in Patients With Metastatic or Locally Advanced Leiomyosarcoma","status":"RECRUITING","sponsor":"Italian Sarcoma Group","startDate":"2021-10-29","conditions":"Leiomyosarcoma of Ovary, Soft Tissue Sarcoma","enrollment":100},{"nctId":"NCT07493382","phase":"NA","title":"Retlirafusp Alfa Injection Combined Chemotherapy for Perioperative Treatment of Esophagogastric Junction Adenocarcinoma: A Single-Arm, Phase II Study of Safety and Efficacy","status":"NOT_YET_RECRUITING","sponsor":"Tianjin Medical University Cancer Institute and Hospital","startDate":"2026-04-01","conditions":"GEJ Adenocarcinoma","enrollment":30},{"nctId":"NCT07240688","phase":"","title":"Association Between Lingual Retraction and Hemodynamic Changes in Patients Receiving Dental Treatment Under General Anesthesia","status":"RECRUITING","sponsor":"Kırıkkale University","startDate":"2025-10-13","conditions":"Trigeminocardiac Reflex, Hemodynamic Changes, Dental Procedures","enrollment":85},{"nctId":"NCT03952598","phase":"PHASE2","title":"Studying the Biology of IDH-mutant Gliomas Via Longitudinal Observation of 2-hydroxyglutarate (2-HG) Using MR Spectroscopy","status":"SUSPENDED","sponsor":"National Cancer Institute (NCI)","startDate":"2019-10-16","conditions":"Glioma, Gliomas, High Grade Glioma","enrollment":42},{"nctId":"NCT06923774","phase":"","title":"European Real-World Registry for Use of the Ion Endoluminal System","status":"RECRUITING","sponsor":"Intuitive Surgical","startDate":"2025-09-09","conditions":"Pulmonary Nodule, Lung Cancer","enrollment":1200},{"nctId":"NCT04082429","phase":"PHASE3","title":"Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia Without Inhibitors","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novo Nordisk A/S","startDate":"2019-11-13","conditions":"Haemophilia A Without Inhibitors, Haemophilia B Without Inhibitors","enrollment":156},{"nctId":"NCT05120830","phase":"PHASE1, PHASE2","title":"NTLA-2002 in Adults With Hereditary Angioedema (HAE)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Intellia Therapeutics","startDate":"2021-12-10","conditions":"Hereditary Angioedema","enrollment":37},{"nctId":"NCT06293352","phase":"NA","title":"Real-component vs All-cement Articulating Spacers for Periprosthetic Knee Infection","status":"RECRUITING","sponsor":"Northwestern University","startDate":"2024-08-08","conditions":"Prosthetic-joint Infection, Knee Infection, Arthroplasty Complications","enrollment":153},{"nctId":"NCT05939414","phase":"PHASE3","title":"An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2024-03-12","conditions":"Oligometastatic Prostate Cancer (OMPC)","enrollment":450},{"nctId":"NCT07137624","phase":"NA","title":"Motor Imagery and Action Observation for Gait Function in MS","status":"RECRUITING","sponsor":"Hacettepe University","startDate":"2026-01-03","conditions":"Multiple Sclerosis","enrollment":20},{"nctId":"NCT05917522","phase":"PHASE2","title":"Assessment of Biomarker-Guided CNI Substitution In Kidney Transplantation","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2023-12-07","conditions":"Kidney Transplant","enrollment":800},{"nctId":"NCT04677816","phase":"PHASE2","title":"Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2021-10-22","conditions":"Triple Negative Breast Cancer, Vitamin D Deficiency, Invasive Breast Cancer","enrollment":50},{"nctId":"NCT04597359","phase":"PHASE2","title":"To Evaluate if Green Tea Can be Effective in Reducing the Progression of Prostate Cancer in Men on Close Monitoring","status":"ACTIVE_NOT_RECRUITING","sponsor":"ECOG-ACRIN Cancer Research Group","startDate":"2021-10-05","conditions":"Prostate Carcinoma","enrollment":360},{"nctId":"NCT07392957","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of CTX-009 With or Without CTX-471 for Recurrent Glioblastoma","status":"NOT_YET_RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2026-04-30","conditions":"Glioblastoma","enrollment":54},{"nctId":"NCT04462406","phase":"PHASE2","title":"Using Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With Unresectable Stage IIIB-IV Melanoma, The PET-Stop Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"ECOG-ACRIN Cancer Research Group","startDate":"2021-02-09","conditions":"Advanced Melanoma, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8","enrollment":150},{"nctId":"NCT04742634","phase":"PHASE1, PHASE2","title":"Pre-emptive Therapy With DEC-C to Improve Outcomes in MDS Patients With Measurable Residual Disease Post Allogeneic Hematopoietic Cell Transplant","status":"RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2022-05-12","conditions":"Myelodysplastic Syndromes","enrollment":209},{"nctId":"NCT07282418","phase":"PHASE1, PHASE2","title":"Behavioral Economic Attributes of Recreation","status":"RECRUITING","sponsor":"Rush University Medical Center","startDate":"2026-04-01","conditions":"Cardiometabolic Health Indicators","enrollment":120},{"nctId":"NCT06372470","phase":"","title":"Personalised Dose Optimisation of Zestril Supported by the Digital Blood Pressure Diary in a Primary Care Environment in England: Pragmatic Observational Pilot Study for Remote Hypertension Treatment","status":"COMPLETED","sponsor":"Closed Loop Medicine","startDate":"2024-04-15","conditions":"Uncomplicated Hypertension","enrollment":20},{"nctId":"NCT07476716","phase":"NA","title":"Peer-modeled Intervention","status":"NOT_YET_RECRUITING","sponsor":"KU Leuven","startDate":"2026-05-01","conditions":"Cardio-metabolic Health","enrollment":157},{"nctId":"NCT06406114","phase":"PHASE2","title":"Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2025-05-05","conditions":"Drug Allergy, Cephalosporin Allergy, Drug Hypersensitivity","enrollment":300},{"nctId":"NCT04102098","phase":"PHASE3","title":"A Study of Atezolizumab Plus Bevacizumab Versus Active Surveillance as Adjuvant Therapy in Patients With Hepatocellular Carcinoma at High Risk of Recurrence After Surgical Resection or Ablation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2019-12-31","conditions":"Carcinoma, Hepatocellular","enrollment":668},{"nctId":"NCT06998524","phase":"PHASE3","title":"A Study to Assess the Efficacy and Safety of Emicizumab in Participants With Type 3 Von Willebrand Disease","status":"RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2025-06-27","conditions":"Von Willebrand Disease, Type 3","enrollment":75},{"nctId":"NCT05726279","phase":"NA","title":"PROtecting Maternal Brains From Injury and Stroke","status":"TERMINATED","sponsor":"Columbia University","startDate":"2023-05-04","conditions":"Preeclampsia, Maternal Hypertension","enrollment":26},{"nctId":"NCT05638945","phase":"NA","title":"Determining the Preliminary Efficacy of the Emergency Department Delirium Screening and Detection Program","status":"COMPLETED","sponsor":"Northwell Health","startDate":"2022-11-28","conditions":"Delirium","enrollment":3000},{"nctId":"NCT07118670","phase":"PHASE4","title":"High Dose Eylea for Proliferative Diabetic Retinopathy Outcomes","status":"ACTIVE_NOT_RECRUITING","sponsor":"Edward Wood, MD","startDate":"2025-12-08","conditions":"Proliferative Diabetic Retinopathy (PDR)","enrollment":40},{"nctId":"NCT06476262","phase":"","title":"Occupational Gaps After Mild Stroke: a Single-Center Observational Study","status":"COMPLETED","sponsor":"Grosmaire","startDate":"2023-02-13","conditions":"Stroke, Occupational Problems","enrollment":50},{"nctId":"NCT06931717","phase":"PHASE3","title":"A Clinical Study to Assess the Efficacy of Adjuvant Immunotherapy With Cemiplimab in Patients With Surgically Removed Non-small Cell Lung Cancer Who Have Not Received Prior Chemotherapy","status":"RECRUITING","sponsor":"ETOP IBCSG Partners Foundation","startDate":"2026-01-12","conditions":"Non-Small Cell Lung Cancer","enrollment":390},{"nctId":"NCT06510374","phase":"PHASE3","title":"Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer","status":"RECRUITING","sponsor":"Ferring Pharmaceuticals","startDate":"2024-10-01","conditions":"Intermediate Risk Non-Muscle Invasive Bladder Cancer","enrollment":454},{"nctId":"NCT04119544","phase":"NA","title":"Mirror Therapy Rehabilitation of the Upper Limb After Stroke (NEURO-MIROIR 2)","status":"RECRUITING","sponsor":"Clinique Les Trois Soleils","startDate":"2019-12-10","conditions":"Stroke","enrollment":66},{"nctId":"NCT07277231","phase":"PHASE3","title":"A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia","status":"RECRUITING","sponsor":"BeOne Medicines","startDate":"2026-01-22","conditions":"Chronic Lymphocytic Leukemia","enrollment":500},{"nctId":"NCT02135042","phase":"PHASE2, PHASE3","title":"Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA","status":"ACTIVE_NOT_RECRUITING","sponsor":"NRG Oncology","startDate":"2014-04-21","conditions":"Epstein-Barr Virus Infection, Stage II Nasopharyngeal Carcinoma, Stage III Nasopharyngeal Carcinoma","enrollment":685},{"nctId":"NCT07477236","phase":"NA","title":"MyVitalC: Sleep and Everyday Headache Management","status":"RECRUITING","sponsor":"Efforia, Inc","startDate":"2026-01-24","conditions":"Sleep, Headaches","enrollment":100},{"nctId":"NCT07478471","phase":"","title":"Observational Study of Raxibacumab in Sporadic Cases of Systemic Anthrax","status":"NOT_YET_RECRUITING","sponsor":"Emergent BioSolutions","startDate":"2027-05","conditions":"Infections, Bacterial","enrollment":10},{"nctId":"NCT05842330","phase":"PHASE3","title":"Benefits of ADHD Treatment in Detained People","status":"RECRUITING","sponsor":"Stéphanie Baggio","startDate":"2024-01-01","conditions":"ADHD","enrollment":150},{"nctId":"NCT07054541","phase":"PHASE4","title":"A Novel Echocardiography-Guided Strategy for Percutateous Closure of Atrial Septal Defect Assisted by PannaWire","status":"NOT_YET_RECRUITING","sponsor":"Chinese Academy of Medical Sciences, Fuwai Hospital","startDate":"2026-03-14","conditions":"Atrial Septal Defect (ASD)","enrollment":666},{"nctId":"NCT06446739","phase":"NA","title":"LoW Dose-Intensity vs. Standard Dose-Intensity COntinuous Renal ReplaceMent Therapy in Critically Ill Patients (WISDOM)","status":"RECRUITING","sponsor":"University of Alberta","startDate":"2024-11-14","conditions":"Acute Kidney Injury, Dialysis; Complications","enrollment":100},{"nctId":"NCT06326749","phase":"NA","title":"Effectiveness of Modified Graded Motor Imagery Training in Stroke Patients","status":"COMPLETED","sponsor":"Inonu University","startDate":"2024-06-15","conditions":"Graded Motor Imagery, Stroke, Action Observation Training","enrollment":46},{"nctId":"NCT07475923","phase":"","title":"Molecular Surveillance In Early Breast Cancer Using The Tumor-Informed ctDNA Assay Myriad Genetics Precise MRD Test; A Prospective Observational Multicenter Study (The MRD Molecular Surveillance Study)","status":"NOT_YET_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2026-08-26","conditions":"Molecular Surveillance, Breast Cancer, ctDNA","enrollment":300},{"nctId":"NCT07313891","phase":"PHASE3","title":"A Study of Adjuvant NDV-01 (Sustained-release Gemcitabine-docetaxel) for the Treatment of Intermediate Risk NMIBC Following TURBT","status":"WITHDRAWN","sponsor":"Relmada Therapeutics, Inc.","startDate":"2026-05-01","conditions":"Bladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive), Bladder (Urothelial, Transitional Cell) Cancer, Urothelial Carcinoma Bladder","enrollment":""},{"nctId":"NCT04608149","phase":"","title":"Prospective, Multi-center, Single-arm, Observational Study. US FDA 522 Pediatric Post Market Surveillance Study.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Medtronic - MITG","startDate":"2021-01-20","conditions":"Acute Kidney Injury, Fluid Overload","enrollment":36},{"nctId":"NCT06075953","phase":"PHASE2","title":"DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment","status":"RECRUITING","sponsor":"QuantumLeap Healthcare Collaborative","startDate":"2024-02-17","conditions":"Ductal Carcinoma in Situ","enrollment":400},{"nctId":"NCT07467408","phase":"","title":"Treatment of Mechanical Low Back Pain With High-Intensity Focused Ultrasound (HIFU)","status":"NOT_YET_RECRUITING","sponsor":"Consorci Sanitari de Terrassa","startDate":"2026-04-01","conditions":"Lumbago","enrollment":60},{"nctId":"NCT06129864","phase":"PHASE3","title":"A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2023-12-14","conditions":"Locally Advanced Head and Neck Squamous Cell Carcinoma","enrollment":1145},{"nctId":"NCT07361289","phase":"","title":"A Study to Assess the Real-World Effectiveness of Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopathy in China","status":"RECRUITING","sponsor":"Bristol-Myers Squibb","startDate":"2026-01-15","conditions":"Hypertrophic Cardiomyopathy","enrollment":500},{"nctId":"NCT07279948","phase":"","title":"A Single-arm Observational Study to Characterize the Demographic, Clinical Features and Outcomes of a Brazilian Cohort of Patients With Lung Cancer.","status":"NOT_YET_RECRUITING","sponsor":"AstraZeneca","startDate":"2026-05-30","conditions":"Lung Cancer","enrollment":477},{"nctId":"NCT07474844","phase":"NA","title":"Structured TXI-RDI Integration for Endoscopic Resection","status":"WITHDRAWN","sponsor":"Medical College of Wisconsin","startDate":"2026-01-01","conditions":"Polyp Colorectal, Endoscopic Mucosal Resection","enrollment":""},{"nctId":"NCT07470203","phase":"","title":"Pyrotinib Combined With Trastuzumab and Pertuzumab for Maintenance Therapy in HER2-Positive Advanced Breast Cancer","status":"NOT_YET_RECRUITING","sponsor":"Peking University Cancer Hospital & Institute","startDate":"2026-03-31","conditions":"HER2-positive Breast Cancer","enrollment":42},{"nctId":"NCT05966636","phase":"NA","title":"LASER Pilot Project","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2024-02-01","conditions":"Acquired Absence of Lower Limb, Scar Condition and Fibrosis of the Skin","enrollment":10},{"nctId":"NCT04289480","phase":"","title":"Safety and Effectiveness of ENTERPRISE 2 Device in the Endovascular Treatment of Intracranial Aneurysms","status":"ACTIVE_NOT_RECRUITING","sponsor":"Medos International SARL","startDate":"2020-07-30","conditions":"Intracranial Aneurysm","enrollment":164},{"nctId":"NCT02445391","phase":"PHASE3","title":"Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy","status":"ACTIVE_NOT_RECRUITING","sponsor":"ECOG-ACRIN Cancer Research Group","startDate":"2015-10-20","conditions":"Estrogen Receptor Negative, HER2/Neu Negative, Invasive Breast Carcinoma","enrollment":415},{"nctId":"NCT07471516","phase":"PHASE1, PHASE2","title":"Zoledronic Acid Treatment in Patients With Congenital Dyserythropoietic Anemia","status":"RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2026-02-25","conditions":"Congenital Dyserythropoietic Anemia (CDA)","enrollment":2},{"nctId":"NCT07247279","phase":"","title":"Epidemiological Study of Treatment Approaches in AChR-Antibody Positive Generalized Myasthenia Gravis in Russia","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2025-12-23","conditions":"Rare Diseases, Generalized Myasthenia Gravis (gMG)","enrollment":450},{"nctId":"NCT06909253","phase":"","title":"Ravulizumab Treatment Outcomes in Patients With Generalized Myasthenia Gravis","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2025-05-15","conditions":"Myasthenia Gravis, Generalized","enrollment":50},{"nctId":"NCT07462468","phase":"PHASE1","title":"A Phase 1 Clinical Study to Evaluate the Safety and Efficacy of WSK-IM02 in Patients With Platinum-resistant Recurrent Ovarian Cancer.","status":"NOT_YET_RECRUITING","sponsor":"WestVac Biopharma Co., Ltd.","startDate":"2026-03-10","conditions":"Platinum-resistant Recurrent Ovarian Cancer (PROC)","enrollment":36},{"nctId":"NCT06186765","phase":"NA","title":"F15 Recharge Free Axonics SNM System Clinical Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Axonics, Inc.","startDate":"2023-12-08","conditions":"Urinary Urge Incontinence (UUI), Urinary Frequency (UF), Fecal Incontinence (FI)","enrollment":144},{"nctId":"NCT07443553","phase":"NA","title":"Alcohol Neurolysis and Capsaicin for Postamputation Pain (PAP)","status":"NOT_YET_RECRUITING","sponsor":"Northwestern University","startDate":"2026-02-15","conditions":"Postamputation Pain","enrollment":120},{"nctId":"NCT07466823","phase":"","title":"Classification of Upper and Lower Limb Spasticity Patterns and Their Impact on Quality of Life in Patients With Multiple Sclerosis","status":"RECRUITING","sponsor":"Marmara University","startDate":"2026-01-01","conditions":"Multiple Sclerosis, Spasticity, Spasticity With Multiple Sclerosis","enrollment":75},{"nctId":"NCT06673043","phase":"","title":"Anifrolumab Real-world Treatment Outcomes in Systemic Lupus Erythematosus","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2025-02-28","conditions":"Lupus Erythematosus, Systemic","enrollment":100},{"nctId":"NCT06438640","phase":"NA","title":"Evaluating a Strategy to Improve Pre-Anesthesia Care Discussions (My Anesthesia Choice-Hip Fracture)","status":"RECRUITING","sponsor":"University of Pennsylvania","startDate":"2024-08-15","conditions":"Hip Fractures, Femoral Neck Fractures, Intertrochanteric Fractures","enrollment":1881},{"nctId":"NCT07465991","phase":"NA","title":"The Effect of Digital Cognitive Behavioural Therapy for Insomnia on Physical Activity in Fibromyalgia","status":"RECRUITING","sponsor":"University of Oxford","startDate":"2026-01-01","conditions":"Fibromyalgia","enrollment":142},{"nctId":"NCT04662879","phase":"NA","title":"Early Detection Initiative for Pancreatic Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Pancreatic Cancer Action Network","startDate":"2021-10-14","conditions":"Hyperglycemia, Diabetes Mellitus, Pancreas Ductal Adenocarcinoma","enrollment":8869},{"nctId":"NCT07111663","phase":"","title":"An Observational Study of Individuals With Isolated Dystonia","status":"RECRUITING","sponsor":"Vima Therapeutics","startDate":"2025-06-17","conditions":"Isolated/Primary Dystonia That Affects More Than One Region of the Body","enrollment":200},{"nctId":"NCT05513001","phase":"PHASE3","title":"An Extension Study of Long-term Efficacy, Safety and Tolerability of Remibrutinib in Chronic Spontaneous Urticaria Patients Who Completed Preceding Studies With Remibrutinib","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2022-12-09","conditions":"Chronic Spontaneous Urticaria","enrollment":696},{"nctId":"NCT07463677","phase":"PHASE2","title":"Tunlametinib Combination Therapy in KRAS-Mutated Unresectable Locally Advanced or Metastatic Non-Small Cell Lung Cancer","status":"NOT_YET_RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2026-03-15","conditions":"Lung Cancer (NSCLC)","enrollment":55},{"nctId":"NCT01419561","phase":"PHASE2","title":"Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2011-09-08","conditions":"KSHV Inflammatory Cytokine Syndrome (KICS), KSHV, HHV-8","enrollment":140},{"nctId":"NCT07350759","phase":"","title":"Observational Study Designed to Detect Decompensation of Congestive Heart Failure (dCHF) Using a Non-Invasive Wearable Device","status":"RECRUITING","sponsor":"CHFDX,Inc.","startDate":"2026-03-09","conditions":"Decompensated Chronic Heart Failure","enrollment":60},{"nctId":"NCT04862221","phase":"PHASE2","title":"TReatment for ImmUne Mediated PathopHysiology","status":"RECRUITING","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2022-02-09","conditions":"Acute Liver Failure, Fulminant Hepatic Failure, Hepatic Encephalopathy","enrollment":163},{"nctId":"NCT07461558","phase":"NA","title":"Watchful Waiting Versus Immediate Repair for Occult Contralateral Inguinal Hernias.","status":"RECRUITING","sponsor":"Northwestern University","startDate":"2026-04","conditions":"Inguinal Hernia Bilateral, Inguinal Hernia Unilateral","enrollment":380}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":221,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Therapeutic entecavir group"],"phase":"marketed","status":"active","brandName":"Observation arm","genericName":"Observation arm","companyName":"PENG YUAN","companyId":"peng-yuan","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}